Neuberger Berman Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Neuberger Berman Group's XERS Position: Q3 2026 in Review
Neuberger Berman Group reduced its Xeris Biopharma Holdings (XERS) stake by 8.9% in Q3 2026, selling an estimated $12.4K and leaving 15,157 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.
Neuberger Berman Group first reported a position in XERS in Q2 2018 and has held it in 4 quarters since. The position peaked at $2.18M in Q2 2018. 206 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Neuberger Berman Group held 15,157 shares of Xeris Biopharma Holdings worth $145K as of Q3 2026.
- Neuberger Berman Group sold 1,473 Xeris Biopharma Holdings shares in Q3 2026, an estimated $12.4K.
- Xeris Biopharma Holdings made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #2193 holding.
- Neuberger Berman Group first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 4 quarters since.
- Neuberger Berman Group's Xeris Biopharma Holdings position peaked at $2.18M in Q2 2018.
- 206 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.